Pharmarise Holdings Corporation (TYO:2796)
Japan flag Japan · Delayed Price · Currency is JPY
489.00
-2.00 (-0.41%)
Jul 31, 2026, 3:30 PM JST

Pharmarise Holdings Balance Sheet

Millions JPY. Fiscal year is Jun - May.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Cash & Equivalents
6,0124,9117,1504,7423,991
Cash & Short-Term Investments
6,0124,9117,1504,7423,991
Cash Growth
22.42%-31.31%50.78%18.82%-13.31%
Accounts Receivable
1,1077351,439605479
Other Receivables
2,6383,0502,1173,4123,786
Receivables
3,7453,7853,5564,0174,265
Inventory
2,8124,1462,6452,2902,302
Other Current Assets
595397386323320
Total Current Assets
13,16413,23913,73711,37210,878
Property, Plant & Equipment
7,6217,2096,1986,0106,355
Long-Term Investments
3392,4842,2962,0082,139
Goodwill
7,2576,8005,9172,7483,220
Other Intangible Assets
345466502502409
Long-Term Accounts Receivable
158----
Long-Term Deferred Tax Assets
1,6521,723834778741
Long-Term Deferred Charges
----1
Other Long-Term Assets
2,1412222
Total Assets
32,68031,92429,48623,42123,746

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Accounts Payable
6,6276,6475,6904,2524,109
Accrued Expenses
885893903805708
Current Portion of Long-Term Debt
4,7812,6392,6553,4902,276
Current Portion of Leases
144158176187214
Current Income Taxes Payable
347284286333429
Other Current Liabilities
1,2261,367978768741
Total Current Liabilities
14,01011,98810,6889,8358,477
Long-Term Debt
9,81011,0539,6545,2167,085
Long-Term Leases
417429264245337
Pension & Post-Retirement Benefits
1,0541,038941791781
Other Long-Term Liabilities
532500499349368
Total Liabilities
25,82325,00822,04616,43617,048

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Common Stock
1,9611,9611,9611,2981,274
Additional Paid-In Capital
2,0912,1862,1771,5531,529
Retained Earnings
2,8932,9383,5304,0143,811
Treasury Stock
-376-471-550-210-210
Comprehensive Income & Other
271253242225203
Total Common Equity
6,8406,8677,3606,8806,607
Minority Interest
17498010591
Shareholders' Equity
6,8576,9167,4406,9856,698
Total Liabilities & Equity
32,68031,92429,48623,42123,746

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Total Debt
15,15214,27912,7499,1389,912
Net Cash (Debt)
-9,140-9,368-5,599-4,396-5,921
Net Cash Growth
-----
Net Cash Per Share
-766.78-827.45-532.02-352.52-477.64
Filing Date Shares Outstanding
11.511.3611.249.439.35
Total Common Shares Outstanding
11.511.3611.249.439.35
Working Capital
-8461,2513,0491,5372,401
Book Value Per Share
594.65604.44654.62729.93706.43
Tangible Book Value
-762-3999413,6302,978
Tangible Book Value Per Share
-66.25-35.1283.69385.12318.41
Land
3,227----
Buildings
9,024----
Machinery
1,982----
Construction In Progress
169----